OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $599,259 Invested

Case Western Reserve University

Paul Tesar, PhD

Therapeutic neuroprotection in Alzheimer’s disease through controlling toxic astrocytes

  • Funding Amount: $599,259
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Degeneration
  • Status: Active